Large genome databases are starting to reveal critical health information—even about people who have not contributed their DNA.
A leading researcher issues a call for pills that deliver a full course of treatment in one swallow.
To motivate healthy behavior, device companies and employers embrace social tools and insights from behavioral science.
Nobel Prize winners raise alarm over genetic engineering of humans.
Peter Thiel was the first large investor in Facebook. Now he’s turning his investing skills to biotechnology.
Gene-editing companies say research on altering the DNA of human reproductive cells is dangerous and unethical.
A startup called Thync will sell electrodes that you put on your head to improve your mood. The results may vary to a surprising degree.
Scientists are developing ways to edit the DNA of tomorrow’s children. Should they stop before it’s too late?
Scientific advances and new business models are spurring investor confidence in biomedical-related ventures.
A global network of millions of genomes could be medicine’s next great advance.
Availability: 1-2 years